We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
You must tell DVLA if you have muscular dystrophy - download the correct form to let them know.
Specialist teams can use this template to send an email, following a phone call and before an appointment, for suspected spinal muscular atrophy (SMA).
These FAQs explain spinal muscular atrophy (SMA), the benefits and limits of early treatment, how screening will work, and what families can expect.
Specialist teams can use this checklist when phoning families to give a screen positive result for spinal muscular atrophy (SMA).
Information and advice for parents of babies with suspected spinal muscular atrophy (SMA) following newborn blood spot screening.
Laboratories can use this template to refer babies with a screen-positive result for SMA to the relevant regional neuromuscular centre (RNMC).
Projects granted during 2014 that have a primary purpose of translational and applied research: human musculoskeletal disorders.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).